Effect of Grape Seed Extract on Blood Pressure

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether an 8-week intervention with grape seed extract is effective in reducing daytime ambulatory blood pressure in male and postmenopausal female with elevated daytime blood pressure values.

Clinical Trial Description

Background: High blood pressure is a major risk factor for morbidity and mortality from stroke, heart disease, and end-stage renal disease. Several studies have shown that dietary polyphenols derived from fruits and vegetables (including those from grape products) can lower blood pressure in both normotensive and hypertensive subjects.

Study objectives: Primary objective: To study, in subjects with elevated blood pressure levels, the effects of grape seed extract high in polyphenols, on daytime ambulatory systolic and diastolic blood pressure (SBP and DBP, respectively). Secondary objective: To explore mechanistic pathways responsible for the blood pressure lowering efficacy in case a blood pressure lowering effect is shown.

Study population: Each treatment group will consist of 35 men and postmenopausal women (35-75 years of age) with daytime SBP between 120 and 159 mmHg. The total number of subjects will be 70.

Study design: This study will have a randomized, double-blind, placebo-controlled parallel design with 2 treatments, a 1-week run-in period, and an 8-week intervention period. The 2 treatments will consist of placebo capsules and capsules with grape seed extract.

Study outcomes: Daytime ambulatory blood pressure (ABP) will be measured every 20 minutes for 2 x 12 hours at baseline and 2 x 12 hours at the end of intervention. Furthermore, before and after the intervention period, 24-hour urine will be collected and 2 blood samples will be taken in order to investigate mechanistic pathways and platelet function. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00869193
Study type	Interventional
Source	Unilever R&D
Contact
Status	Completed
Phase	N/A
Start date	March 2009
Completion date	July 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03626363` - Mindfulness and Neural Cardiovascular Control in Humans	N/A
Recruiting	`NCT05121337` - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension	N/A
Active, not recruiting	`NCT05062161` - Sleep Duration and Blood Pressure During Sleep	N/A
Completed	`NCT04953650` - Intermittent Fasting Towards Elevated Blood Pressure	N/A
Enrolling by invitation	`NCT06033417` - Walking and Blood Pressure in Older Adults With Respiratory Impairment.	N/A
Completed	`NCT03716960` - The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.	N/A
Completed	`NCT05533268` - Effect of Mental and Physical Training on Blood Pressure	N/A
Completed	`NCT05029427` - Effect of Oat Beta Glucan in Managing Blood Pressure	N/A
Recruiting	`NCT05370625` - To Assess TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure	N/A
Not yet recruiting	`NCT06376812` - No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women	N/A
Not yet recruiting	`NCT06348225` - Post-exercise Hot Water Immersion to Improve Overnight Blood Pressure	N/A
Active, not recruiting	`NCT04766424` - Sleep Technology Intervention to Target Cardiometabolic Health	N/A
Recruiting	`NCT05297708` - Office, Home, and Ambulatory Blood Pressure
Completed	`NCT04298944` - Association of Mood With Risk for Atherosclerosis
Recruiting	`NCT05397535` - Baduanjin Lower Elevated Blood PreSsure Study	N/A
Completed	`NCT05928676` - Open Label Clinical Trial of Vascanox® HP on Nitric Oxide and Blood Pressure	N/A
Not yet recruiting	`NCT03764020` - Trial of Oral Melatonin in Elevated Blood Pressure	Phase 3
Suspended	`NCT03508739` - Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition	Phase 3
Active, not recruiting	`NCT05469503` - Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure	N/A
Recruiting	`NCT05955040` - Treatment of Elevated Blood Pressures in Early Pregnancy	Phase 2